scholarly article | Q13442814 |
P819 | ADS bibcode | 1996PNAS...9313991M |
P356 | DOI | 10.1073/PNAS.93.24.13991 |
P8608 | Fatcat ID | release_xpmpivzcmjbm7bsvhzxsg3e5hy |
P932 | PMC publication ID | 19482 |
P698 | PubMed publication ID | 8943048 |
P5875 | ResearchGate publication ID | 14264324 |
P50 | author | Linda A Sherman | Q42403205 |
P2093 | author name string | V Nguyen | |
S Malarkannan | |||
N Shastri | |||
T Serwold | |||
P2860 | cites work | A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human Melanoma | Q24319940 |
Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection | Q24561706 | ||
Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules | Q28248180 | ||
The molecular basis of allorecognition | Q28268279 | ||
A p16INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma | Q28296086 | ||
Sequence analysis of peptides bound to MHC class II molecules | Q28303686 | ||
TAP1 mutant mice are deficient in antigen presentation, surface class I molecules, and CD4-8+ T cells | Q28589574 | ||
The human cytomegalovirus US11 gene product dislocates MHC class I heavy chains from the endoplasmic reticulum to the cytosol | Q29618773 | ||
Peptides presented to the immune system by the murine class II major histocompatibility complex molecule I-Ad | Q30311282 | ||
Characterization of peptides bound to the class I MHC molecule HLA-A2.1 by mass spectrometry | Q30434686 | ||
An HLA-A2-restricted tyrosinase antigen on melanoma cells results from posttranslational modification and suggests a novel pathway for processing of membrane proteins | Q30442847 | ||
Direct identification of an endogenous peptide recognized by multiple HLA-A2.1-specific cytotoxic T cells. | Q30447379 | ||
Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines. | Q30463850 | ||
Structure of peptides associated with class I and class II MHC molecules | Q30463866 | ||
Detection of rare antigen-presenting cells by the lacZ T-cell activation assay suggests an expression cloning strategy for T-cell antigens | Q30990189 | ||
Altered mouse mammary tumor virus transcript synthesis in T-cell lymphoma cells | Q33257177 | ||
Positive selection of thymocytes | Q33366862 | ||
Characterization of an incompletely assembled major histocompatibility class I molecule (H-2Kb) associated with unusually long peptides: implications for antigen processing and presentation | Q35217978 | ||
A molecular model of MHC class-I-restricted antigen processing | Q35347353 | ||
Cell biology of antigen processing and presentation to major histocompatibility complex class I molecule-restricted T lymphocytes | Q35533657 | ||
Endogenously synthesized peptide with an endoplasmic reticulum signal sequence sensitizes antigen processing mutant cells to class I-restricted cell-mediated lysis | Q36230273 | ||
Trimming of antigenic peptides in an early secretory compartment | Q36364157 | ||
A rare cryptic translation product is presented by Kb major histocompatibility complex class I molecule to alloreactive T cells | Q36365601 | ||
Mouse mammary tumor virus-related sequences in mouse lymphocytes are inducible by 12-O-tetradecanoyl phorbol-13-acetate | Q36586966 | ||
A ubiquitous protein is the source of naturally occurring peptides that are recognized by a CD8+ T-cell clone | Q36699072 | ||
Differential expression of endogenous mouse mammary tumor virus genes during development of the BALB/c mammary gland. | Q36865336 | ||
A standardized nomenclature for endogenous mouse mammary tumor viruses. | Q36887951 | ||
Measurement of ligand-induced activation in single viable T cells using the lacZ reporter gene | Q37505330 | ||
Antigen recognition by class I-restricted T lymphocytes | Q38201551 | ||
Genes coding for T-cell-defined tum transplantation antigens: point mutations, antigenic peptides, and subgenic expression | Q38786713 | ||
Proteins Encoded by Mouse Mammary Tumour Virus | Q40108479 | ||
Structure and processing of the mouse mammary tumor virus glycoprotein precursor pr73env. | Q40307739 | ||
Superantigens: bacterial and viral proteins that manipulate the immune system | Q40385479 | ||
Single T cell probes for antigen/MHC expression | Q40404793 | ||
From defined human tumor antigens to effective immunization? | Q40422861 | ||
MHC class I-restricted processing of transmembrane proteins. Mechanism and biologic significance | Q40439436 | ||
Tumor antigens recognized by T lymphocytes | Q40661131 | ||
MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation | Q40807437 | ||
Peptides naturally presented by MHC class I molecules | Q40898177 | ||
Needles in haystacks: identifying specific peptide antigens for T cells | Q41049065 | ||
Processing of major histocompatibility class I-restricted antigens in the endoplasmic reticulum | Q41354524 | ||
Endogenous generation and presentation of the ovalbumin peptide/Kb complex to T cells | Q41562754 | ||
On the nature of peptides involved in T cell alloreactivity | Q41657428 | ||
Isolation of an endogenously processed immunodominant viral peptide from the class I H–2Kb molecule | Q41714857 | ||
Identification of classical minor histocompatibility antigen as cell-derived peptide | Q41747528 | ||
Cell-type-specific recognition of allogeneic cells by alloreactive cytotoxic T cells: a consequence of peptide-dependent allorecognition. | Q42024285 | ||
A superantigen encoded in the open reading frame of the 3' long terminal repeat of mouse mammary tumour virus. | Q42616060 | ||
LacZ inducible, antigen/MHC-specific T cell hybrids | Q44031720 | ||
Tumor Rejection After Direct Costimulation of CD8 + T Cells by B7-Transfected Melanoma Cells | Q44615042 | ||
The role of MHC class I molecules in the generation of endogenous peptide/MHC complexes. | Q45955221 | ||
Peptide-dependent recognition of H-2Kb by alloreactive cytotoxic T lymphocytes | Q46197161 | ||
Uneven tissue distribution of minor histocompatibility proteins versus peptides is caused by MHC expression | Q48720785 | ||
Cellular peptide composition governed by major histocompatibility complex class I molecules | Q53885926 | ||
Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules | Q55042699 | ||
Molecular interactions required for triggering alloantigen-specific cytolytic T lymphocytes | Q61140758 | ||
A naturally occurring peptide recognized by alloreactive CD8+ cytotoxic T lymphocytes in association with a class I MHC protein | Q68157843 | ||
Identification of a tap-dependent leader peptide recognized by alloreactive T cells specific for a class Ib antigen | Q71655418 | ||
Tissue distribution of natural peptides derived from a ubiquitous dehydrogenase, including a novel liver-specific peptide that demonstrates the pronounced specificity of low affinity T cell reactions | Q71689098 | ||
The role of self peptides in the allogeneic cross-reactivity of CTLs | Q71700920 | ||
TAP1-dependent peptide translocation in vitro is ATP dependent and peptide selective | Q72873502 | ||
P433 | issue | 24 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Mouse mammary tumor virus | Q1775519 |
P304 | page(s) | 13991-13996 | |
P577 | publication date | 1996-11-01 | |
P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
P1476 | title | The mouse mammary tumor virus env gene is the source of a CD8+ T-cell-stimulating peptide presented by a major histocompatibility complex class I molecule in a murine thymoma | |
P478 | volume | 93 |
Q32037072 | Allo- and self-restricted cytotoxic T lymphocytes against a peptide library: evidence for a functionally diverse allorestricted T cell repertoire |
Q43655803 | ER aminopeptidases generate a unique pool of peptides for MHC class I molecules. |
Q40773084 | Efficient Chromosomal Mapping of a Methylcholanthrene- Induced Tumor Antigen by CTL Immunoselection |
Q26852000 | Endogenous retroviruses and the development of cancer |
Q91322258 | Endogenously Expressed Antigens Bind Mammalian RNA via Cationic Domains that Enhance Priming of Effector CD8 T Cells by DNA Vaccination |
Q30763625 | Identification of an MHC class I-restricted autoantigen in type 1 diabetes by screening an organ-specific cDNA library. |
Q35683920 | Identities of P2 and P3 Residues of H-2Kb-Bound Peptides Determine Mouse Ly49C Recognition |
Q38793023 | Immune responses to endogenous retroelements: taking the bad with the good |
Q33683433 | Interplays between mouse mammary tumor virus and the cellular and humoral immune response. |
Q73878430 | Minor histocompatibility antigens |
Q28253285 | Minors Held by Majors: The H13 Minor Histocompatibility Locus Defined as a Peptide/MHC Class I Complex |
Q38565385 | Targeting tumor vasculature: expanding the potential of DNA cancer vaccines. |
Q40895891 | The role of peptides in T cell alloreactivity is determined by self-major histocompatibility complex molecules |
Search more.